In a 5‑day‑old term neonate with severe hypotension, thready brachial pulse, absent femoral pulses, hepatomegaly, and no improvement after oxygen and a 10 mL/kg fluid bolus, which medication is most appropriate next: adenosine, ceftriaxone, hydrocortisone, or prostaglandin E1?

Prostaglandin E1 Is the Most Appropriate Next Medication

This neonate requires immediate prostaglandin E1 infusion at 0.05–0.1 µg/kg/min because the constellation of absent femoral pulses, weak brachial pulse, hepatomegaly, and shock unresponsive to fluid resuscitation at 5 days of life indicates ductal-dependent congenital heart disease with imminent ductal closure. 1

Clinical Recognition of Ductal-Dependent Cardiac Lesions

The differential pulse examination is pathognomonic:

• Absent femoral pulses with weak brachial pulse signifies differential upper- and lower-extremity perfusion, the hallmark of ductal-dependent systemic circulation (e.g., critical coarctation of the aorta, interrupted aortic arch, or hypoplastic left heart syndrome). 1
• Timing at 5 days of life aligns precisely with physiologic ductal closure, the typical decompensation point for ductal-dependent lesions. 1
• Hepatomegaly with 6-second capillary refill indicates severe low cardiac output and right-heart failure in this setting. 1
• Hypotension refractory to a 10 mL/kg fluid bolus points to cardiogenic rather than hypovolemic shock. 1

The American College of Critical Care Medicine explicitly recommends that any newborn with shock, hepatomegaly, or differential pulses/pressures be started on prostaglandin infusion pending echocardiographic confirmation. 1

Why Prostaglandin E1 Must Be Given Immediately

• Prostaglandin E1 pharmacologically reopens the closing ductus arteriosus, thereby restoring systemic perfusion to the lower body in ductal-dependent lesions. 1, 2
• Postponing prostaglandin E1 until echocardiography is performed can lead to irreversible end-organ injury or death. 1
• Smooth muscle of the ductus arteriosus is especially sensitive to alprostadil, and administration reopens the closing ductus in newborn mammals. 2
• In infants with restricted systemic blood flow, alprostadil increases pH in those with acidosis, increases systemic blood pressure, and decreases the ratio of pulmonary artery pressure to aortic pressure. 2

Dosing Protocol

• Initiate IV infusion at 0.05–0.1 µg/kg/min. 1
• If there is no clinical response, titrate the dose up to 0.4 µg/kg/min. 1
• Continue the infusion until echocardiography either confirms or excludes a ductal-dependent cardiac lesion. 1
• Alprostadil must be infused continuously because it is very rapidly metabolized, with as much as 80% metabolized in one pass through the lungs. 2

Why the Other Options Are Inappropriate

Adenosine

• Adenosine is indicated only for supraventricular tachycardia with a narrow QRS complex; it does not treat sinus tachycardia that is a compensatory response to low cardiac output. 1
• The heart rate of 194 bpm in this neonate is a physiologic response to shock, not a primary arrhythmia requiring adenosine. 1

Ceftriaxone

• Ceftriaxone (or other antibiotics) addresses possible sepsis but does not resolve the life-threatening ductal closure; differential pulses require prostaglandin therapy. 1
• While broad-spectrum antibiotics (e.g., ampicillin + gentamicin) should be administered because sepsis remains in the differential diagnosis, they must be given after prostaglandin E1 is started. 1
• The differential pulse examination mandates evaluation for ductal-dependent congenital heart disease and cannot be attributed solely to sepsis. 1

Hydrocortisone

• Hydrocortisone is reserved for catecholamine-resistant shock with documented adrenal insufficiency and should not be used before catecholamines are administered. 1
• The American College of Critical Care Medicine recommends hydrocortisone replacement only for adrenal or hypothalamic-pituitary-adrenal axis insufficiency in the context of shock with low cardiac index, low blood pressure, and low systemic vascular resistance. 3
• This patient has not yet received inotropic support, making hydrocortisone premature. 1

Concurrent Management After Prostaglandin E1 Initiation

• Continue fluid resuscitation cautiously, watching for worsening hepatomegaly that would suggest fluid overload in cardiogenic shock. 1
• If shock persists, start inotropic support with dopamine 5–9 µg/kg/min plus dobutamine up to 10 µg/kg/min. 1
• Escalate to epinephrine 0.05–0.3 µg/kg/min for catecholamine-resistant shock. 1
• Obtain an urgent echocardiogram to confirm the diagnosis and guide definitive surgical planning. 1
• Administer broad-spectrum antibiotics (e.g., ampicillin + gentamicin) because sepsis remains in the differential diagnosis. 1

Critical Pitfalls to Avoid

• Do not delay prostaglandin E1 while awaiting echocardiography in any neonate with differential pulses and shock. 1
• Be aware that apnea occurs in approximately 10–12% of neonates on prostaglandin E1; ensure readiness for airway support. 1
• Avoid excessive fluid administration in suspected cardiogenic shock, as it can worsen pulmonary edema without improving cardiac output. 1
• Do not administer acetaminophen to neonates on prostaglandin E1, as acetaminophen has antiprostaglandin properties that can reduce ductal patency and necessitate increased alprostadil dosing. 4
• Monitor for gastric outlet obstruction (antral foveolar hyperplasia or hypertrophic pyloric stenosis) if prolonged prostaglandin E1 therapy is required, as this complication is associated with total dose and duration of treatment. 5